W E Wung|S B Howell - JoVE Visualize

Showing results (141-150 of 242) with videos related to

Pageof 25

Sort By:

Cancer Research|June 15, 1989

Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamoleS B Howell, D Hom, R Sanga, et al.

Cancer Research|October 19, 2001

Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repairA Kondo, R Safaei, M Mishima, et al.

Cancer Research|January 1, 1988

Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patientsT C Chan, G L Coppoc, S Zimm, et al.

International Journal of Cancer|March 17, 2001

Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoterX Lin, D P Gately, D Hom, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.

Cancer Research|August 1, 1989

Dipyridamole enhancement of etoposide sensitivityS B Howell, D K Hom, R Sanga, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administrationP G Lindnér, D Heath, S B Howell, et al.

AJNR. American Journal of Neuroradiology|June 5, 1998

An organ-preserving selective arterial chemotherapy strategy for head and neck cancerC W Kerber, W H Wong, S B Howell, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003

Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolitesA Fedier, M Schlamminger, V A Schwarz, et al.

Cancer Research|March 14, 2001

P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.

Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:

Pageof 25

Cancer Research|June 15, 1989

Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamoleS B Howell, D Hom, R Sanga, et al.

Cancer Research|October 19, 2001

Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repairA Kondo, R Safaei, M Mishima, et al.

Cancer Research|January 1, 1988

Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patientsT C Chan, G L Coppoc, S Zimm, et al.

International Journal of Cancer|March 17, 2001

Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoterX Lin, D P Gately, D Hom, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.

Cancer Research|August 1, 1989

Dipyridamole enhancement of etoposide sensitivityS B Howell, D K Hom, R Sanga, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administrationP G Lindnér, D Heath, S B Howell, et al.

AJNR. American Journal of Neuroradiology|June 5, 1998

An organ-preserving selective arterial chemotherapy strategy for head and neck cancerC W Kerber, W H Wong, S B Howell, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003

Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolitesA Fedier, M Schlamminger, V A Schwarz, et al.

Cancer Research|March 14, 2001

P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.

Pageof 25